NIDCR News 2017

Two NIDCR-supported resource centers—part of NIDCR’s Dental, Oral, and Craniofacial Tissue Regeneration Consortium (DOCTRC)—are currently soliciting pre-proposals for their Interdisciplinary Translational Project (ITP) programs. The one-year awards of up to $150,000 will enable ITP teams to access and collaborate with a resource center to establish technology readiness toward submission of IND/IDE applications to the FDA for therapies in the dental, oral, and craniofacial realm.

Douglas Sheeley, ScD, has been selected to be the deputy director of NIDCR. Dr. Sheeley is an accomplished researcher, educator, and leader who has been with NIH for more than 17 years. He will join the institute on October 16.

Every weekday morning for the past year, dental students Jason Berglund and John Le depart their dorm-like residence on the NIH campus, walk 5 minutes to their respective labs in NIDCR’s Building 30, and dive into the day’s tasks.
Despite remarkable advances in recent decades, cancer often remains an elusive foe. A major reason is treatment resistance—when a tumor no longer responds to a chemotherapy drug—coupled with metastasis, in which the cancer spreads to other parts of the body. Most cancer-related deaths are caused by metastases.
The body’s barrier sites, such as the skin, mouth and intestines, are continually exposed to potentially harmful foreign substances and infectious agents, and they are also home to a diverse array of harmless microbes called commensal microorganisms.

NIDCR News Archive

2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014